| Stage | APOG | % of rev | BCC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $391M | 100.00% | $1.8B | 100.00% | BCC ×4.61 |
| Gross profit | $96M | 24.59% | $296M | 16.40% | APOG +8.2pp |
| Operating income | $33M | 8.56% | $56M | 3.10% | APOG +5.5pp |
| Pre-tax income | $30M | 7.78% | $51M | 2.82% | APOG +5.0pp |
| Net income | $22M | 5.72% | $36M | 2.02% | APOG +3.7pp |
| Stage | APOG | BCC | Gap · A − B |
|---|---|---|---|
| Revenue | $391M100.00% | $1.8B100.00% | BCC ×4.61 |
| Gross profit | 24.59%$96M | 16.40%$296M | APOG +8.2pp |
| Operating income | 8.56%$33M | 3.10%$56M | APOG +5.5pp |
| Pre-tax income | 7.78%$30M | 2.82%$51M | APOG +5.0pp |
| Net income |
| 5.72%$22M |
| 2.02%$36M |
| APOG +3.7pp |
None
No disclosed counterparties: APOG.